NO20002477L - Transgene modeller av inflammatoriske sykdommer - Google Patents
Transgene modeller av inflammatoriske sykdommerInfo
- Publication number
- NO20002477L NO20002477L NO20002477A NO20002477A NO20002477L NO 20002477 L NO20002477 L NO 20002477L NO 20002477 A NO20002477 A NO 20002477A NO 20002477 A NO20002477 A NO 20002477A NO 20002477 L NO20002477 L NO 20002477L
- Authority
- NO
- Norway
- Prior art keywords
- interleukin
- knockout
- inflammatory diseases
- mammal
- expression
- Prior art date
Links
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 238000012301 transgenic model Methods 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 108010063738 Interleukins Proteins 0.000 abstract 2
- 101001076407 Homo sapiens Interleukin-1 receptor antagonist protein Proteins 0.000 abstract 1
- 102000015696 Interleukins Human genes 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000001771 impaired effect Effects 0.000 abstract 1
- 230000000415 inactivating effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000037361 pathway Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/033—Rearing or breeding invertebrates; New breeds of invertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
- A01K2267/0325—Animal model for autoimmune diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0368—Animal model for inflammation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Plant Pathology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Microbiology (AREA)
- Animal Husbandry (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Det beskrives et pattedyr hvor ekspresjonen av ett eller flere interleukin-gener er blitt undertrykt. Nærmere bestemt er det foretatt en inaktiverende delesjon av interleukin-1-reseptorantagonistgenet for å produsere et ikke-humant knockout- pattedyr med nedsatt eller fullstendig undertrykket ekspresjon av det endogene gen. Fremgangsmåter for fremstilling av slike knockout-pattedyr og for bruk av knockout- dyrene til evaluering av effekten av terapeutiske midler og regimer for behandling av sykdommer eller forstyrrelser assosiert med alvorlig forstyrrelse i interleukin-veiene, er også beskrevet.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9723835.6A GB9723835D0 (en) | 1997-11-13 | 1997-11-13 | Interleukin knockout |
PCT/US1998/024287 WO1999025857A2 (en) | 1997-11-13 | 1998-11-13 | Transgenic models of inflammatory disease |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20002477D0 NO20002477D0 (no) | 2000-05-12 |
NO20002477L true NO20002477L (no) | 2000-07-12 |
Family
ID=10821919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20002477A NO20002477L (no) | 1997-11-13 | 2000-05-12 | Transgene modeller av inflammatoriske sykdommer |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1030926A2 (no) |
JP (1) | JP2001523467A (no) |
KR (1) | KR20010015814A (no) |
AU (1) | AU1796699A (no) |
BR (1) | BR9814142A (no) |
CA (1) | CA2309807A1 (no) |
GB (1) | GB9723835D0 (no) |
HU (1) | HUP0004352A2 (no) |
IL (1) | IL136013A0 (no) |
NO (1) | NO20002477L (no) |
PL (1) | PL340829A1 (no) |
TR (1) | TR200001356T2 (no) |
WO (1) | WO1999025857A2 (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6437216B1 (en) | 1997-11-13 | 2002-08-20 | Interleukin Genetics Inc. | Transgenic models of inflammatory disease |
WO2001056606A1 (fr) * | 2000-01-31 | 2001-08-09 | Santen Pharmaceutical Co., Ltd. | Remedes pour troubles ophtalmiques |
KR20030067204A (ko) * | 2002-02-07 | 2003-08-14 | 한국생명공학연구원 | 퍼록시레독신-ⅱ 유전자 결손 생쥐 및 이의 생산방법 |
EP1723235B1 (en) * | 2004-02-12 | 2012-06-27 | The Walter And Eliza Hall Institute Of Medical Research | Modified cells that co-express blimp1 and a reporter molecule and methods of using the same |
JP2009183176A (ja) * | 2008-02-05 | 2009-08-20 | Univ Of Tokyo | Il−1タイプiiレセプター遺伝子の欠損変異体マウス |
JP5186637B2 (ja) * | 2009-07-30 | 2013-04-17 | 国立大学法人富山大学 | トランスジェニック非ヒト哺乳動物およびその利用 |
WO2019235839A1 (ko) * | 2018-06-05 | 2019-12-12 | 사회복지법인 삼성생명공익재단 | 그레이브스 안병증 표현형 동물 모델, 그의 제조방법 및 그레이브스 안병증 치료물질 스크리닝 방법 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1269989B (it) * | 1994-09-21 | 1997-04-16 | Dompe Spa | Antagonisti recettoriali di il-1 ad aumentata attivita' inibitoria |
EP0787179A4 (en) * | 1994-10-20 | 1999-05-19 | Merck & Co Inc | TRANSGENIC ANIMALS WITH INTERLEUKIN-1-g (b) DEFICIENCY |
US6210877B1 (en) * | 1997-03-10 | 2001-04-03 | Interleukin Genetics, Inc. | Prediction of coronary artery disease |
-
1997
- 1997-11-13 GB GBGB9723835.6A patent/GB9723835D0/en not_active Ceased
-
1998
- 1998-11-13 TR TR2000/01356T patent/TR200001356T2/xx unknown
- 1998-11-13 CA CA002309807A patent/CA2309807A1/en not_active Abandoned
- 1998-11-13 KR KR1020007005243A patent/KR20010015814A/ko not_active Application Discontinuation
- 1998-11-13 WO PCT/US1998/024287 patent/WO1999025857A2/en not_active Application Discontinuation
- 1998-11-13 PL PL98340829A patent/PL340829A1/xx unknown
- 1998-11-13 HU HU0004352A patent/HUP0004352A2/hu unknown
- 1998-11-13 EP EP98962809A patent/EP1030926A2/en not_active Withdrawn
- 1998-11-13 AU AU17966/99A patent/AU1796699A/en not_active Abandoned
- 1998-11-13 JP JP2000521220A patent/JP2001523467A/ja active Pending
- 1998-11-13 IL IL13601398A patent/IL136013A0/xx unknown
- 1998-11-13 BR BR9814142-2A patent/BR9814142A/pt not_active Application Discontinuation
-
2000
- 2000-05-12 NO NO20002477A patent/NO20002477L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BR9814142A (pt) | 2000-10-03 |
TR200001356T2 (tr) | 2000-08-21 |
AU1796699A (en) | 1999-06-07 |
NO20002477D0 (no) | 2000-05-12 |
HUP0004352A2 (en) | 2001-03-28 |
KR20010015814A (ko) | 2001-02-26 |
PL340829A1 (en) | 2001-02-26 |
WO1999025857A3 (en) | 1999-07-15 |
JP2001523467A (ja) | 2001-11-27 |
CA2309807A1 (en) | 1999-05-27 |
EP1030926A2 (en) | 2000-08-30 |
WO1999025857A2 (en) | 1999-05-27 |
IL136013A0 (en) | 2001-05-20 |
GB9723835D0 (en) | 1998-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Shemer et al. | Structure of the imprinted mouse Snrpn gene and establishment of its parental-specific methylation pattern | |
Guy et al. | A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome | |
Tait-Burkard et al. | Livestock 2.0–genome editing for fitter, healthier, and more productive farmed animals | |
Zhou et al. | Generation of CRISPR/Cas9-mediated gene-targeted pigs via somatic cell nuclear transfer | |
Nordin et al. | Epigenetic regulation of the Igf2/H19 gene cluster | |
Tueting et al. | The phenotypic characteristics of heterozygous reeler mouse | |
Giesige et al. | AAV-mediated follistatin gene therapy improves functional outcomes in the TIC-DUX4 mouse model of FSHD | |
Cheung et al. | Novel targeted deregulation of c-Myc cooperates with Bcl-X L to cause plasma cell neoplasms in mice | |
De Murcia et al. | Requirement of poly (ADP-ribose) polymerase in recovery from DNA damage in mice and in cells | |
Chen et al. | Endogenous expression of HrasG12V induces developmental defects and neoplasms with copy number imbalances of the oncogene | |
Giacometti et al. | Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2 | |
O'Keefe et al. | Chemical genetics define the roles of p38α and p38β in acute and chronic inflammation | |
ATE315085T1 (de) | Transgene mäuse mit veränderter apolipoprotein e- expression und testverfahren. | |
DE69233477D1 (de) | Transgene nicht-menschliche tiere ohne prionprotein | |
BR9811659A (pt) | Clonagem de porcos usando-se núcleos doadores de células diferenciadas | |
ATE431849T1 (de) | Zufuhr transposonbasierter vektoren zu fortpflanzungsorganen | |
Hernández-Santana et al. | Keratinocyte interleukin-36 receptor expression orchestrates psoriasiform inflammation in mice | |
Suzuki et al. | Generation and characterization of RAG2 knockout pigs as animal model for severe combined immunodeficiency | |
NO20002477L (no) | Transgene modeller av inflammatoriske sykdommer | |
BR9811657A (pt) | Clonagem usando-se núcleos doadores oriundos de células diferenciadas não-carentes de soro | |
Ding et al. | Siglecg limits the size of B1a B cell lineage by down-regulating NFκB activation | |
Morishita et al. | Deafness due to degeneration of cochlear neurons in caspase-3-deficient mice | |
Siegmund et al. | Frontline: Interferon regulatory factor‐1 as a protective gene in intestinal inflammation: role of TCR γ δ T cells and interleukin‐18‐binding protein | |
IL146296A0 (en) | Cell reprogramming | |
Kaklamanos et al. | Experimental models of sjögren’s syndrome: Differences and similarities with human disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |